NCT01999699
- Conditions
- Blood-Borne Infections, Communicable Diseases, DNA Virus Infections, +8 more
- Locations
-
- Johnson County Clinical Trials Lenexa, Kansas, United States
Clinical trial condition
Hepatitis B
Explore clinical trials studying Hepatitis B. Study availability and eligibility vary by location and protocol.
458 public trials
28 recruiting studies
Hepatitis B trial results
NCT00426712
- Conditions
- Blood-Borne Infections, Chronic Disease, Communicable Diseases, +21 more
- Locations
-
- West Coast Clinical Trials Costa Mesa, California, United States
- Twin Cities Clinical Research Brooklyn Center, Minnesota, United States
- Covance Austin, Texas, United States
- University of Virginia Health System, Nephrology Clinical Research Center Charlottesville, Virginia, United States
Completed
Safety and Efficacy of HEPLISAV™ Hepatitis B Virus Vaccine Compared With Engerix-B® Vaccine
NCT00435812
- Conditions
- Blood-Borne Infections, Communicable Diseases, DNA Virus Infections, +8 more
- Locations
-
- Edmonton, Alberta, Canada
- Surrey, British Columbia, Canada
- Winnipeg, Manitoba, Canada
- Mount Pearl, Newfoundland and Labrador, Canada
NCT01037114
- Conditions
- Blood-Borne Infections, Communicable Diseases, DNA Virus Infections, +12 more
- Locations
-
- GSK Investigational Site Ghent, Belgium
NCT02548325
- Conditions
- Blood-Borne Infections, Communicable Diseases, DNA Virus Infections, +8 more
- Locations
-
- Mútua de Terrassa Terrassa, Barcelona, Spain
Completed
Hepatitis B Vaccine for Non-responders
NCT03415672
- Conditions
- Blood-Borne Infections, Communicable Diseases, DNA Virus Infections, +8 more
- Locations
-
- Vaxinfectio - Antwerp University Antwerp, Belgium
- Ziekenhuis Oost-Limburg Genk, Belgium
- Maastricht UMC Maastricht, Netherlands
NCT02003703
- Conditions
- Blood-Borne Infections, Communicable Diseases, DNA Virus Infections, +9 more
- Locations
-
- Hospital Gustavo Fricke Viña del Mar, Valparaiso, Chile
NCT01777295
- Conditions
- Blood-Borne Infections, Communicable Diseases, DNA Virus Infections, +8 more
- Locations
-
- GSK Investigational Site Antwerp, Belgium
Completed
Safety and Immunogenicity of HBAI20 Hepatitis B Vaccine in Naive Adults and Non-responders
NCT02540538
- Conditions
- Blood-Borne Infections, Communicable Diseases, DNA Virus Infections, +8 more
- Locations
-
- Maastricht UMC Maastricht, Netherlands
NCT02749864
- Conditions
- Blood-Borne Infections, Communicable Diseases, DNA Virus Infections, +14 more
- Locations
-
- Hospital Universitario Marqués de Valdecilla Santander, Cantabria, Spain
- Hospital Clínico Universitario de Valencia Valencia, Spain
- Hospital Universitario Puerta de Hierro-Majadahonda Madrid, Spain